Lv4
726 积分 2022-11-01 加入
Phase 1 Study of Anito-cel, a d -Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
18分钟前
待确认
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study
2天前
已完结
Multi-omics reveals evolution from CD7-negative T cell dysregulation to EBV-positive LPD after CD7 CAR-T therapy
17天前
已完结
The allogeneic eDN70(-) CAR-T Cells Without TCR or MHC Editing Exhibit Enhanced Persistence and Function
20天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
28天前
已完结
Rapid CAR-T manufacturing with low-intensity priming enhances CAR-T cell fitness and limits inflammatory programming in a phase 1 study
1个月前
已完结
Phase 1 Study of Anito-cel, a d -Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
1个月前
已完结
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
1个月前
已完结
Phase 1 Study of Anito-cel, a d -Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
1个月前
已完结
In vivo CAR T cell engineering: design principles and open questions
1个月前
已完结